BMC women's health

BMC women's health
Audio Summaries

Every issue of BMC women's health moves the field forward, but reading every paper cover-to-cover isn't realistic. OSLR turns each article into a 3-minute audio summary so you can stay current while you commute, round, or work out.

666 audio summariesNLM Catalog

Specialties

BMC women's health covers research in these specialties.

Recent summaries

The latest articles summarized from BMC women's health.

Long-term risk of second primary malignancies and symptomatic heart failure after pegylated liposomal doxorubicin versus conventional anthracycline-based chemotherapy in early-stage breast cancer survivors: a single-center experience.

Nov 20, 2026

This retrospective single-center study of 1,372 early-stage breast cancer patients asked whether pegylated liposomal doxorubicin (PLD) or conventional anthracyclines increase long-term risk of second primary malignancies (SPM) or symptomatic heart failure (HF) compared with no chemotherapy, and how their survival compares. Neither anthracycline regimen was associated with a significantly higher SPM or HF risk than the reference group, and after 1:4 cardinality matching, disease-free and overall survival did not differ between PLD and conventional anthracyclines. The small PLD cohort (51 patients) and few events, however, mean the findings cannot establish equivalence or definitive cardiac safety for PLD.

HDAC2/Parkin axis regulates mitochondrial dysfunction and mitophagy in polyendocrine metabolic ovarian syndrome.

Nov 20, 2026

This study asks whether the HDAC2/Parkin axis drives DHT-induced mitochondrial dysfunction and impaired mitophagy in granulosa cells, and whether HDAC inhibition could serve as a therapy for polycystic ovary-like metabolic disease (PMOS). In KGN granulosa cells, HDAC2 knockdown reversed DHT-induced mitochondrial damage, whereas Parkin knockdown abolished this protection, and HDAC2 was found to bind Parkin and affect its acetylation. In a DHEA plus high-fat diet rat model, the HDAC inhibitor SAHA improved estrous cycles, hormone and insulin resistance markers, ovarian morphology, and PINK1/Parkin-mediated mitophagy, supporting HDAC2/Parkin as a potential therapeutic target.

Association between internet use and unmet need for family planning among currently pregnant women in Bangladesh: evidence from BDHS 2022.

Nov 20, 2026

This cross-sectional study of 4,370 currently pregnant women in the 2022 Bangladesh Demographic and Health Survey asks whether internet use is linked to unmet need for family planning. Overall, 41% of women had unmet need, and internet users had 1.83 times higher adjusted odds of unmet need than non-users, with stronger associations among women with no formal education, early first births, and those in certain divisions such as Barishal, Rajshahi, and Sylhet. The authors conclude that internet use is significantly associated with higher unmet need, suggesting that family planning programs should target these higher-burden groups and that digital engagement warrants further research.

Randomized controlled trial of adjunctive zinc-containing vaginal hydrogel following fluconazole therapy for vulvovaginal candidiasis.

Nov 19, 2026

This randomized controlled trial tested whether adding a zinc-containing vaginal hydrogel after oral fluconazole improves cure of acute vulvovaginal candidiasis compared with fluconazole alone in 54 women. The hydrogel did not significantly improve clinical cure, symptoms, or other primary and secondary measures, though mycological cure at week 12 was numerically higher (65.6% vs. 40.9%, p = 0.097). In an exploratory post-clearance subgroup, culture negativity was maintained in all hydrogel-treated participants versus 64.7% of controls (p = 0.021), a signal that warrants larger placebo-controlled trials before any conclusions about recurrence prevention.

Psychosexual outcomes in HPV-positive women with abnormal cervical cytology: a prospective comparison of clinical surveillance and excisional treatment.

Nov 19, 2026

This prospective observational study asked whether psychosexual outcomes in HPV-positive women with abnormal cervical cytology are driven by HPV positivity itself or by excisional treatment, comparing 80 women under clinical surveillance with 48 who underwent excision over six months. Women under surveillance showed greater improvement in depressive symptoms (BDI) but a higher rate of worsening sexual dysfunction (FSFI-6) than those treated excisionally, whose sexual function changes were more stable. The findings suggest that psychosexual outcomes differ by management pathway and support individualized counseling and routine psychological and sexual health assessment in HPV-related care.

Retrospective analysis of HER2 expression status as a prognostic factor in PTK6-positive triple-negative breast cancer.

Nov 19, 2026

This retrospective study of 94 PTK6-positive triple-negative breast cancer patients asked whether HER2-low expression affects prognosis and how it relates to PTK6 status. Sixty-five percent of patients were HER2-low, a status associated with older age, but HER2-low versus HER2-zero status did not significantly change disease-free or overall survival. Age and nodal stage emerged as independent prognostic factors, highlighting heterogeneity within PTK6-positive TNBC.

Cross-cultural adaptation of the Malay version of the menstrual practice needs scale (MPNS-36), and assessment of menstrual practice needs among female university students in Malaysia.

Nov 19, 2026

This study translated and validated the Malay version of the 36-item Menstrual Practice Needs Scale (MPNS-36), finding acceptable internal consistency (Cronbach's alpha 0.752 to 0.893). The authors then used it to ask what menstrual practice needs female university students in Malaysia face, and found substantial unmet needs (mean overall score 2.19, with the lowest score in material reliability concerns), with no significant sociodemographic predictors identified, although maternal tertiary education showed a non-significant trend toward higher scores.

Prevalence of high-risk human papillomavirus and cytological correlation in Gujarati women: implications for regional screening and vaccination strategies.

Nov 19, 2026

This cross-sectional study of 9,706 married women aged 30 and older in Gujarat, India, asked how common high-risk HPV genotypes are and how they relate to cervical cytological abnormalities. Overall hrHPV prevalence was 4.9%, with non-16/18 types accounting for most infections, and HPV-16 showed the strongest association with high-grade squamous intraepithelial lesions (HSIL), especially when co-infected with HPV-18. The authors conclude that extended-genotype vaccination, genotype-informed screening, and reproductive health interventions such as delaying early marriage and pregnancy are needed to support cervical cancer elimination efforts in the region.

Biopsychosocial factors associated with menstrual pain, menstrual attitudes, health literacy, and physical activity across age-based cohorts: a cross-sectional comparative study.

Nov 18, 2026

This cross-sectional study of 1,220 women with primary dysmenorrhea asked whether menstrual pain, menstrual attitudes, health literacy, and physical activity differ across age-based cohorts (Generations Z, Y, and X) and which menstrual attitudes are linked to pain. Pain, menstrual attitudes, and health literacy differed significantly across cohorts, with the youngest cohort reporting the highest pain and the oldest the lowest health literacy, while physical activity did not differ. In adjusted analyses, viewing menstruation as bothersome or natural was positively associated with pain, whereas denying its effects was negatively associated, though the cross-sectional design precludes causal conclusions.

Performance of a DNA methylation marker panel in cervical samples from women with abnormal cytology findings.

Nov 18, 2026

This study evaluated whether the GynTect DNA methylation panel (ASTN1, DLX1, ITGA4, RXFP3, SOX17, ZNF671) can serve as a more selective triage test than the p16/Ki-67 Dual Stain for women with abnormal cervical cytology. In 1,000 samples with cytology of LSIL or worse, GynTect was positive in 27.7% of cases versus 88.3% for p16/Ki-67, with positivity rising steadily with cytological and histological severity and all four carcinomas testing positive. The authors conclude that GynTect may offer higher selectivity for high-grade disease and reduce overtreatment, though prospective validation in HPV-screening triage populations is still needed.

Listen to BMC women's health

14-day free trial. Every new article, summarized in ~3 minutes.